Skip to content

Author

Xiao-Dong Wang

We have 3 of 24 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Radiation-Induced Cell-Death States in Cancer: Toward Biomarker-Guided Radioimmunotherapy.

Radiotherapy can convert local tumor injury into systemic antitumor immunity, but this effect depends less on the nominal mode of cell death than on the tissue state that follows irradiation. This narrative review reframes radiation-induced regulated cell death around four functional outputs: antigen preservation, prod...

Xiao-Dong Wang, Wei-Yi Gao, Qian-Qian Wang et al. · 0 citations
Review Open access Sep 2026

Immune-pressure redistribution in resistance to PD-1/PD-L1 blockade: mechanisms, biomarkers, and therapeutic design

PD-1/PD-L1 blockade can produce durable tumor control, yet primary, adaptive, and acquired resistance remain common. Existing accounts often catalogue resistance by cellular compartment, obscuring the coordinated nature of tumor adaptation. Here, we introduce immune-pressure redistribution as a treatment-oriented frame...

Xiao-Dong Wang, Jia-Yi Liu, Alifujiang Hairulajiang et al. · 0 citations
Review Open access Jul 2026

Ecosystem-matched reprogramming of the tumor–immune microenvironment to overcome cancer immunotherapy resistance

It is proposed that future progress will depend on ecosystem-matched combinations guided by spatial biomarkers, on-treatment pharmacodynamics, and adaptive trial designs capable of linking mechanism to clinical decision-making.

Xiao-Dong Wang, Qian-Qian Wang, Wei-Yi Gao et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.